Neurotherapeutics Symposium 2019 – accelerating the pace of translation in neurological emergencies by enhancing diverse workforce in neuroscience and promoting transdisciplinary team science

2019 年神经治疗研讨会 — 通过增强神经科学领域的多元化劳动力和促进跨学科团队科学，加快神经系统紧急情况的转化步伐

• 批准号: 9763196
• 负责人: Robert C Griggs
• 金额: $ 2万
• 依托单位: UNIVERSITY OF FLORIDA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-15 至 2021-04-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9763196
• 关键词: Acute; Address; Adopted; Biomedical Engineering; Brain; Brain Injuries; Caring; Clinical; Clinical Sciences; Collaborations; Complex; Coupled; Critical Care; Crystallization; Development; Diagnosis; Directories; Disease; Diverse Workforce; Educational workshop; Environment; Evaluation; Evidence Based Medicine; Expert Opinion; Fostering; Foundations; Funding; Funding Opportunities; Future; Generations; Goals; Guidelines; Incentives; Individual; Injury; Institutes; International; Journals; Knowledge; Lead; Link; Manuscripts; Mentors; Minority Groups; Nervous system structure; Neurological emergencies; Neurology; Neurosciences; Participant; Physiology; Pilot Projects; Postdoctoral Fellow; Process; Productivity; Publishing; Recording of previous events; Rehabilitation therapy; Research; Research Personnel; Role; Science; Scientist; Secondary Prevention; Seeds; Technology; Therapeutic; Time; Training; Translational Research; Translations; Underrepresented Groups; Underrepresented Minority; United States National Institutes of Health; Universities; Vulnerable Populations; Woman; Work; career; career development; clinical practice; cohesion; digital; driving force; emergency settings; experience; frontier; graduate student; infancy; innovation; lectures; meetings; minority investigator; nervous system disorder; neurological recovery; novel; posters; recruit; smartphone Application; symposium; therapeutic target

PROJECT SUMMARY There is an unmet need in advancing therapeutic approaches in neurocritical care. This field is in its infancy of implementation of translational research, and most of clinical practice is led by expert opinion-derived guidelines informed by studies with low quality of evidence. The Neurotherapeutics Symposium 2019 – Neurological Emer- gencies is a conference that will be held in Rochester/NY aiming at accelerating the pace of translational neu- rology with a focus on severe acute neurologic disorders. This conference centers on diversity enhancement in the neuroscience workforce to bring innovative and creative perspectives to complex scientific questions, and engagement with transdisciplinary team science to facilitate the dissemination of new findings across clinical neuroscientists. Underrepresented minorities have been heavily involved in both the planning and in the confer- ence itself as confirmed speakers and moderators, demonstrating the commitment of this project to inclusion excellence in the neuroscience workforce. The target audience includes clinician-scientists at the forefront of care of neurocritically ill individuals, neuroscientists and bioengineers, rehabilitation experts, and trainees com- mitted to an academic career; a close collaboration with organizations that will assist with recruitment of at- tendees from underrepresented groups will be actively sought. Approximately 75-100 participants are anticipated to join the meeting, with an expected 40% representation of women and nationally underrepresented groups. The conference also sets the stage for long-term networking to nurture collaborations and stimulate new lines of research though a smartphone app that includes a directory with attendees, a link to NIH Matchmaker and online discussion capability. All speakers will select a landmark manuscript relevant to their lecture, which will be avail- able to all attendees ahead of time, so that the yield of subsequent discussions is increased. Sessions will include workshops on team science formation, underexplored funding opportunities and career development, and brief dynamic lectures followed by blocks of lively discussions on the frontiers of critical care neurotherapeutics. Fur- ther, this symposium provides a platform for promising early investigators/trainees to establish and deepen men- toring relationships with more established investigators, which will foster career development and future collab- orations. All speakers and attendees are encouraged to submit their work for poster presentations (all also avail- able in the app), to provide another opportunity for discussions and brainstorming of new projects. At the end of the conference, attendees are expected to apply for pilot funding by submitting their team science project along with a specific aims draft including a scientific question and hypothesis. The use of digital technology connecting profiles and promoting networking beyond the duration of the conference coupled with the availability of seed funding for pilot projects that arise from collaborations formed at the conference are incentives to facilitate the scientific productivity of this innovative and impactful initiative. Abstracts and the proceedings of the meeting will be published in the Neurocritical Care journal.

项目摘要 在神经重症监护中推进治疗方法存在未满足的需求。这一领域正处于起步阶段， 转化研究的实施，以及大多数临床实践都是由专家意见指导的 由低质量证据的研究提供信息。神经治疗研讨会2019 -神经Emer- gencies是一个会议，将在罗切斯特/纽约举行，旨在加快翻译neu的步伐， 重点关注严重急性神经系统疾病。本次会议的中心是多样性增强， 神经科学工作者为复杂的科学问题带来创新和创造性的观点， 参与跨学科团队科学，以促进新发现在临床 神经科学家代表性不足的少数民族大量参与了规划和协商， 作为确认的发言人和主持人，展示了该项目对包容性的承诺 优秀的神经科学工作者目标受众包括处于最前沿的临床科学家， 护理神经重症患者，神经科学家和生物工程师，康复专家和学员com- 致力于学术生涯;与组织密切合作，这将有助于招聘在- 将积极寻求代表性不足群体的候选人。预计约有75-100人参加 参加会议，预计妇女和全国代表性不足的群体将占40%。 会议还为长期网络搭建了舞台，以培育合作并刺激新的生产线。 通过智能手机应用程序进行研究，该应用程序包括与会者目录，NIH Matchmaker和在线链接 讨论能力。所有演讲者将选择一个具有里程碑意义的手稿相关的演讲，这将是有益的- 能够提前通知所有与会者，以便提高后续讨论的产量。会议将包括 关于团队科学形成、未充分开发的资金机会和职业发展的讲习班， 充满活力的讲座，随后是关于重症监护神经治疗学前沿的热烈讨论。毛皮- 因此，本次研讨会为有前途的早期研究者/学员提供了一个平台，以建立和深化男性- 与更成熟的调查人员建立关系，这将促进职业发展和未来的合作， 演说鼓励所有发言者和与会者提交他们的工作海报介绍（所有也利用- 能够在应用程序），提供另一个机会，讨论和集思广益的新项目。结束时 在这次会议上，与会者有望通过提交他们的团队科学项目沿着申请试点资金。 具有特定目的的草稿，包括科学问题和假设。使用数字技术连接 简介和促进会议结束后的联网，同时提供种子 为会议上形成的合作所产生的试点项目提供资金是促进 这一创新和有影响力的举措的科学生产力。会议摘要和议事录将 发表在《神经重症监护》杂志上。